A Phase II Study of ALIMTA in Patients With Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Abstracts/Posters/Presentations:

• Christopher J. Sweeney, Bruce J. Roth, Donald S. Kaufman, Steven J. Nicol A Phase II Study of ALIMTA in Patients with Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium): A Hoosier Oncology Group Study GU00-13. Accepted as a poster presentation at the ASCO annual meeting May 31-June 3, 2003, Chicago, IL

Manuscripts/Articles:

• CJ Sweeney, BJ Roth, FF Kabbinavar, DJ Vaughn, M Arning, RE Curiel, CK Obasaju, Y Wang, SJ Nichol, DS Kaufman. Phase II Study of Pemetrexed for Second-Line Treatment of Transitional Cell Cancer of the Urothelium: Hoosier Oncology Group GU00-13. J Clin Oncol. 2006 Jul 20;24(21):3451-7. See abstract.